Denna sida på svenska
Loading profile information...

About me

I have an engineering background from the Royal Institute of Technology (KTH) in Stockholm and I obtained my PhD in 2009 at Karolinska Institutet (KI). I did my postdoc at the Institute of Psychiatry, King’s College London and I became an associate professor in 2014 at KI.  I am the head of the Division for Clinical Geriatrics and I have my own research group within the section. I am main supervisor of three PhD student and I have four postdocs in my research group. I am also co-supervisor for six PhD students.

Research description

The aim of my research is to combine different biomarkers looking at patterns of disease. Due to the complexity and heterogeneity of Alzheimer’s disease (AD) and other neurodegenerative disorder, using one biomarker is probably not enough. The focus of my research has long been on structural magnetic resonance imaging investigating patterns of atrophy, but my research extends to other imaging modalities such as MR-spectroscopy, resting state fMRI, MR-diffusion, positron emission tomography (PET) and computer tomography (CT) etc. Further, the combination of neuroimaging biomarkers with CSF and blood markers is of great interest. The need for advanced statistical tools is important when combing large amounts of data from multiple neuroimaging modalities. Combining multiple biomarkers with multivariate tools will hopefully aid in diagnosing the disease in an early stage which is important when effective treatments for AD can be administered, monitor disease progression, target the right population for clinical trial and understand the underlying mechanisms of different diseases.

Publications

27-Hydroxycholesterol impairs neuronal glucose uptake through an IRAP/GLUT4 system dysregulation
Ismail Ma, Mateos L, Maioli S, Merino-serrais P, Ali Z, Lodeiro M, et al
The Journal of experimental medicine 2017;214(3):699-717

Abnormal Structural Brain Connectome in Individuals with Preclinical Alzheimer's Disease
Pereira Jb, Van Westen D, Stomrud E, Strandberg To, Volpe G, Westman E, et al
Cerebral cortex (New York, N.Y. : 1991) 2017;():1-12

A 'Disease Severity Index' to identify individuals with Subjective Memory Decline who will progress to mild cognitive impairment or dementia
Ferreira D, Falahati F, Linden C, Buckley Rf, Ellis Ka, Savage G, et al
Scientific reports 2017;7():44368-

A Multi-Cohort Study of ApoE ɛ4 and Amyloid-β Effects on the Hippocampus in Alzheimer's Disease
Khan W, Giampietro V, Banaschewski T, Barker Gj, Bokde Al, Büchel C, et al
Journal of Alzheimer's disease : JAD 2017;56(3):1159-1174

Amyloid Network Topology Characterizes the Progression of Alzheimer's Disease During the Predementia Stages
Pereira Jb, Strandberg To, Palmqvist S, Volpe G, Van Westen D, Westman E, et al
Cerebral cortex (New York, N.Y. : 1991) 2017;():1-10

Association between cerebrospinal fluid and plasma neurodegeneration biomarkers with brain atrophy in Alzheimer's disease
Pereira Jb, Westman E, Hansson O, Alzheimer's Disease Neuroimaging Initiative
Neurobiology of aging 2017;58():14-29

Atrophy of the Posterior Subiculum Is Associated with Memory Impairment, Tau- and Aβ Pathology in Non-demented Individuals
Lindberg O, Mårtensson G, Stomrud E, Palmqvist S, Wahlund Lo, Westman E, et al
Frontiers in aging neuroscience 2017;9():306-

BRAPH: A graph theory software for the analysis of brain connectivity
Mijalkov M, Kakaei E, Pereira Jb, Westman E, Volpe G, Alzheimer's Disease Neuroimaging Initiative
PloS one 2017;12(8):e0178798-

Cerebrospinal Fluid Biomarkers for the Differential Diagnosis between Alzheimer's Disease and Frontotemporal Lobar Degeneration: Systematic Review, HSROC Analysis, and Confounding Factors
Rivero-santana A, Ferreira D, Perestelo-pérez L, Westman E, Wahlund Lo, Sarría A, et al
Journal of Alzheimer's disease : JAD 2017;55(2):625-644

Clinical utility and research frontiers of neuroimaging in movement disorders
Nobili F, Westman E, Kogan Rv, Pereira Jb, Massa F, Grazzini M, et al
The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of... 2017;61(4):372-385

Cognitive Variability during Middle-Age: Possible Association with Neurodegeneration and Cognitive Reserve
Ferreira D, Machado A, Molina Y, Nieto A, Correia R, Westman E, et al
Frontiers in aging neuroscience 2017;9():188-

Distinct subtypes of Alzheimer's disease based on patterns of brain atrophy: longitudinal trajectories and clinical applications
Ferreira D, Verhagen C, Hernández-cabrera Ja, Cavallin L, Guo Cj, Ekman U, et al
Scientific reports 2017;7():46263-

Imaging biomarkers of dementia: recommended visual rating scales with teaching cases
Wahlund Lo, Westman E, Van Westen D, Wallin A, Shams S, Cavallin L, et al
Insights into imaging 2017;8(1):79-90

Medial temporal lobe atrophy ratings in a large 75-year-old population-based cohort: gender-corrected and education-corrected normative data
Velickaite V, Ferreira D, Cavallin L, Lind L, Ahlström H, Kilander L, et al
European radiology 2017;():-

Monitoring disease progression in mild cognitive impairment: Associations between atrophy patterns, cognition, APOE and amyloid
Falahati F, Ferreira D, Muehlboeck Js, Eriksdotter M, Simmons A, Wahlund Lo, et al
NeuroImage. Clinical 2017;16():418-428

MRI-assessed atrophy subtypes in Alzheimer's disease and the cognitive reserve hypothesis
Persson K, Eldholm Rs, Barca Ml, Cavallin L, Ferreira D, Knapskog Ab, et al
PloS one 2017;12(10):e0186595-

MRI-Based Classification Models in Prediction of Mild Cognitive Impairment and Dementia in Late-Life Depression
Lebedeva Ak, Westman E, Borza T, Beyer Mk, Engedal K, Aarsland D, et al
Frontiers in aging neuroscience 2017;9():13-

Novel genetic loci associated with hippocampal volume
Hibar Dp, Adams Hhh, Jahanshad N, Chauhan G, Stein Jl, Hofer E, et al
NATURE COMMUNICATIONS 2017;:13624-

Quantitative susceptibility mapping differentiates between parkinsonian disorders
Sjöström H, Granberg T, Westman E, Svenningsson P
Parkinsonism & related disorders 2017;():-

Reproducible segmentation of white matter hyperintensities using a new statistical definition
Damangir S, Westman E, Simmons A, Vrenken H, Wahlund Lo, Spulber G
Magma (New York, N.Y.) 2017;30(3):227-237

The Effects of Gene Mutations on Default Mode Network in Familial Alzheimer's Disease
Li X, Westman E, Thordardottir S, Ståhlbom Ak, Almkvist O, Blennow K, et al
Journal of Alzheimer's disease : JAD 2017;56(1):327-334

The Evans' Index revisited: New cut-off levels for use in radiological assessment of ventricular enlargement in the elderly
Brix Mk, Westman E, Simmons A, Ringstad Ga, Eide Pk, Wagner-larsen K, et al
European journal of radiology 2017;95():28-32

The interactive effect of demographic and clinical factors on hippocampal volume: A multicohort study on 1958 cognitively normal individuals
Ferreira D, Hansson O, Barroso J, Molina Y, Machado A, Hernández-cabrera Ja, et al
Hippocampus 2017;27(6):653-667

The worst performance rule with elderly in abnormal cognitive decline
Wallert J, Ekman U, Westman E, Madison G
INTELLIGENCE 2017;:9-17

Different reserve proxies confer overlapping and unique endurance to cortical thinning in healthy middle-aged adults
Ferreira D, Bartrés-faz D, Nygren L, Rundkvist Lj, Molina Y, Machado A, et al
Behavioural brain research 2016;311():375-383

Disrupted Network Topology in Patients with Stable and Progressive Mild Cognitive Impairment and Alzheimer's Disease
Pereira Jb, Mijalkov M, Kakaei E, Mecocci P, Vellas B, Tsolaki M, et al
Cerebral cortex (New York, N.Y. : 1991) 2016;26(8):3476-3493

Electroencephalography Is a Good Complement to Currently Established Dementia Biomarkers
Ferreira D, Jelic V, Cavallin L, Oeksengaard Ar, Snaedal J, Høgh P, et al
Dementia and geriatric cognitive disorders 2016;42(1-2):80-92

Manual Planimetry of the Medial Temporal Lobe Versus Automated Volumetry of the Hippocampus in the Diagnosis of Alzheimer's Disease
Menéndez González M, Suárez-sanmartin E, García C, Martínez-camblor P, Westman E, Simmons A
Cureus 2016;8(3):e544-

Measuring Global Brain Atrophy with the Brain Volume/Cerebrospinal Fluid Index: Normative Values, Cut-Offs and Clinical Associations
Addneuronmed Consortium, Orellana C, Ferreira D, Muehlboeck Js, Mecocci P, Vellas B, et al
NEURODEGENERATIVE DISEASES 2016;16(1-2):77-86

Myo-inositol changes precede amyloid pathology and relate to APOE genotype in Alzheimer disease
Voevodskaya O, Sundgren Pc, Strandberg O, Zetterberg H, Minthon L, Blennow K, et al
Neurology 2016;86(19):1754-61

Novel genetic loci underlying human intracranial volume identified through genome-wide association
Adams Hh, Hibar Dp, Chouraki V, Stein Jl, Nyquist Pa, Rentería Me, et al
Nature neuroscience 2016;19(12):1569-1582

Quantitative validation of a visual rating scale for frontal atrophy: associations with clinical status, APOE e4, CSF biomarkers and cognition
Ferreira D, Cavallin L, Granberg T, Lindberg O, Aguilar C, Mecocci P, et al
European radiology 2016;26(8):2597-610

Targeted delivery of nerve growth factor to the cholinergic basal forebrain of Alzheimer's disease patients: application of a second-generation encapsulated cell biodelivery device
Eyjolfsdottir H, Eriksdotter M, Linderoth B, Lind G, Juliusson B, Kusk P, et al
Alzheimer's research & therapy 2016;8(1):30-

The Effect of Age Correction on Multivariate Classification in Alzheimer's Disease, with a Focus on the Characteristics of Incorrectly and Correctly Classified Subjects
Falahati F, Ferreira D, Soininen H, Mecocci P, Vellas B, Tsolaki M, et al
Brain topography 2016;29(2):296-307

The effect of increased genetic risk for Alzheimer's disease on hippocampal and amygdala volume
Lupton Mk, Strike L, Hansell Nk, Wen W, Mather Ka, Armstrong Nj, et al
Neurobiology of aging 2016;40():68-77

Aberrant cerebral network topology and mild cognitive impairment in early Parkinson's disease
Pereira Jb, Aarsland D, Ginestet Ce, Lebedev Av, Wahlund Lo, Simmons A, et al
Human brain mapping 2015;36(8):2980-95

Alterations in brain leptin signalling in spite of unchanged CSF leptin levels in Alzheimer's disease
Maioli S, Lodeiro M, Merino-serrais P, Falahati F, Khan W, Puerta E, et al
Aging cell 2015;14(1):122-9

A Subset of Cerebrospinal Fluid Proteins from a Multi-Analyte Panel Associated with Brain Atrophy, Disease Classification and Prediction in Alzheimer's Disease
Khan W, Aguilar C, Kiddle Sj, Doyle O, Thambisetty M, Muehlboeck S, et al
PloS one 2015;10(8):e0134368-

Automated CT-based segmentation and quantification of total intracranial volume
Aguilar C, Edholm K, Simmons A, Cavallin L, Muller S, Skoog I, et al
European radiology 2015;25(11):3151-60

Automated Hippocampal Subfield Measures as Predictors of Conversion from Mild Cognitive Impairment to Alzheimer's Disease in Two Independent Cohorts
Alzheimer's Dis Neuroimaging Initi, Addneuromed Consortium, Khan W, Westman E, Jones N, Wahlund Lo, et al
BRAIN TOPOGRAPHY 2015;28(5):746-759

A voxel-based morphometry comparison of the 3.0T ADNI-1 and ADNI-2 volumetric MRI protocols
Brunton S, Gunasinghe C, Jones N, Kempton Mj, Westman E, Simmons A
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY 2015;30(5):531-8

Brain Changes in Alzheimer's Disease Patients with Implanted Encapsulated Cells Releasing Nerve Growth Factor
Alzheimer's Dis Neuroimaging, Ferreira D, Westman E, Eyjolfsdottir H, Almqvist P, Lind G, et al
JOURNAL OF ALZHEIMERS DISEASE 2015;43(3):1059-72

Changes in CSF cholinergic biomarkers in response to cell therapy with NGF in patients with Alzheimer's disease
Karami A, Eyjolfsdottir H, Vijayaraghavan S, Lind G, Almqvist P, Kadir A, et al
Alzheimer's & dementia : the journal of the Alzheimer's Association 2015;11(11):1316-28

Common genetic variants influence human subcortical brain structures
Hibar Dp, Stein Jl, Renteria Me, Arias-vasquez A, Desrivières S, Jahanshad N, et al
Nature 2015;520(7546):224-9

Early astrocytosis in autosomal dominant Alzheimer's disease measured in vivo by multi-tracer positron emission tomography
Schöll M, Carter Sf, Westman E, Rodriguez-vieitez E, Almkvist O, Thordardottir S, et al
Scientific reports 2015;5():16404-

Linking Genetics of Brain Changes to Alzheimer's Disease: Sparse Whole Genome Association Scan of Regional MRI Volumes in the ADNI and AddNeuroMed Cohorts
Khondoker M, Newhouse S, Westman E, Muehlboeck Js, Mecocci P, Vellas B, et al
Journal of Alzheimer's disease : JAD 2015;45(3):851-64

Medial temporal lobe atrophy and depressive symptoms in elderly patients with and without Alzheimer disease
Enache D, Cavallin L, Lindberg O, Farahmand B, Kramberger Mg, Westman E, et al
Journal of geriatric psychiatry and neurology 2015;28(1):40-8

Plasma protein biomarkers of Alzheimer's disease endophenotypes in asymptomatic older twins: early cognitive decline and regional brain volumes
Kiddle Sj, Steves Cj, Mehta M, Simmons A, Xu X, Newhouse S, et al
TRANSLATIONAL PSYCHIATRY 2015;:e584-

Practical cut-offs for visual rating scales of medial temporal, frontal and posterior atrophy in Alzheimer's disease and mild cognitive impairment
Ferreira D, Cavallin L, Larsson Em, Muehlboeck Js, Mecocci P, Vellas B, et al
Journal of internal medicine 2015;278(3):277-90

Preclinical Cerebrospinal Fluid and Volumetric Magnetic Resonance Imaging Biomarkers in Swedish Familial Alzheimer's Disease
Thordardottir S, Stahlbom Ak, Ferreira D, Almkvist O, Westman E, Zetterberg H, et al
JOURNAL OF ALZHEIMERS DISEASE 2015;43(4):1393-402

The influence of negative life events on hippocampal and amygdala volumes in old age: a life-course perspective
Gerritsen L, Kalpouzos G, Westman E, Simmons A, Wahlund Lo, Bäckman L, et al
Psychological medicine 2015;45(6):1219-28

The Use of MRI, CT and Lumbar Puncture in Dementia Diagnostics: Data from the SveDem Registry
Falahati F, Fereshtehnejad Sm, Religa D, Wahlund Lo, Westman E, Eriksdotter M
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS 2015;39(1-2):81-91

Tract Based Spatial Statistic Reveals No Differences in White Matter Microstructural Organization between Carriers and Non-Carriers of the APOE ɛ4 and ɛ2 Alleles in Young Healthy Adolescents
Dell'acqua F, Khan W, Gottlieb N, Giampietro V, Ginestet C, Bouls D, et al
Journal of Alzheimer's disease : JAD 2015;47(4):977-84

White matter changes in familial Alzheimer's disease
Li X, Westman E, Ståhlbom Ak, Thordardottir S, Almkvist O, Blennow K, et al
Journal of internal medicine 2015;278(2):211-8

Alzheimer's disease biomarker discovery using SOMAscan multiplexed protein technology
Addneuromed Consortium, Sattlecker M, Kiddle Sj, Newhouse S, Proitsi P, Nelson S, et al
ALZHEIMERS & DEMENTIA 2014;10(6):724-34

Application of a MRI based index to longitudinal atrophy change in Alzheimer disease, mild cognitive impairment and healthy older individuals in the AddNeuroMed cohort
Addneuromed Consortium, Aguilar C, Muehlboeck Js, Mecocci P, Vellas B, Tsolaki M, et al
FRONTIERS IN AGING NEUROSCIENCE 2014;:145-

Candidate Blood Proteome Markers of Alzheimer's Disease Onset and Progression: A Systematic Review and Replication Study
Kiddle Sj, Sattlecker M, Proitsi P, Simmons A, Westman E, Bazenet C, et al
JOURNAL OF ALZHEIMERS DISEASE 2014;38(3):515-31

Cognitive decline is mediated by gray matter changes during middle age
Ferreira D, Molina Y, Machado A, Westman E, Wahlund Lo, Nieto A, et al
Neurobiology of aging 2014;35(5):1086-94

Cortical Changes Associated with Depression and Antidepressant Use in Alzheimer and Lewy Body Dementia: An MRI Surface-based Morphometric Study
Lebedev Av, Beyer Mk, Fritze F, Westman E, Ballard C, Aarsland D
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY 2014;22(1):4-13.e1

Improving CSF Biomarkers' Performance for Predicting Progression from Mild Cognitive Impairment to Alzheimer's Disease by Considering Different Confounding Factors: A Meta-Analysis
Ferreira D, Rivero-santana A, Perestelo-pérez L, Westman E, Wahlund Lo, Sarría A, et al
Frontiers in aging neuroscience 2014;6():287-

Influence of age, disease onset and ApoE4 on visual medial temporal lobe atrophy cut-offs
Pereira Jb, Cavallin L, Spulber G, Aguilar C, Mecocci P, Vellas B, et al
Journal of internal medicine 2014;275(3):317-30

Initial cognitive decline is associated with cortical thinning in early Parkinson disease
Pereira Jb, Svenningsson P, Weintraub D, Brønnick K, Lebedev A, Westman E, et al
Neurology 2014;82(22):2017-25

Large-scale resting state network correlates of cognitive impairment in Parkinson's disease and related dopaminergic deficits
Lebedev Av, Westman E, Simmons A, Lebedeva A, Siepel Fj, Pereira Jb, et al
Frontiers in systems neuroscience 2014;8():45-

Meta-review of CSF core biomarkers in Alzheimer's disease: the state-of-the-art after the new revised diagnostic criteria
Ferreira D, Perestelo-perez L, Westman E, Wahlund Lo, Sarria A, Serrano-aguilar P
FRONTIERS IN AGING NEUROSCIENCE 2014;:47-

Multiple sclerosis patients lacking oligoclonal bands in the cerebrospinal fluid have less global and regional brain atrophy
Ferreira D, Voevodskaya O, Imrell K, Stawiarz L, Spulber G, Wahlund Lo, et al
Journal of neuroimmunology 2014;274(1-2):149-54

Multivariate data analysis and machine learning in Alzheimer's disease with a focus on structural magnetic resonance imaging
Falahati F, Westman E, Simmons A
Journal of Alzheimer's disease : JAD 2014;41(3):685-708

No differences in hippocampal volume between carriers and non-carriers of the ApoE ε4 and ε2 alleles in young healthy adolescents
Khan W, Giampietro V, Ginestet C, Dell'acqua F, Bouls D, Newhouse S, et al
Journal of Alzheimer's disease : JAD 2014;40(1):37-43

Plasma proteins predict conversion to dementia from prodromal disease
Hye A, Riddoch-contreras J, Baird Al, Ashton Nj, Bazenet C, Leung R, et al
Alzheimer's & dementia : the journal of the Alzheimer's Association 2014;10(6):799-807.e2

Predicting progression of Alzheimer's disease using ordinal regression
Doyle Om, Westman E, Marquand Af, Mecocci P, Vellas B, Tsolaki M, et al
PloS one 2014;9(8):e105542-

Random Forest ensembles for detection and prediction of Alzheimer's disease with a good between-cohort robustness
Lebedev Av, Westman E, Van Westen Gj, Kramberger Mg, Lundervold A, Aarsland D, et al
NeuroImage. Clinical 2014;6():115-25

Regional vulnerability of hippocampal subfields to aging measured by structural and diffusion MRI
Pereira Jb, Valls-pedret C, Ros E, Palacios E, Falcón C, Bargalló N, et al
Hippocampus 2014;24(4):403-14

Structural brain changes associated with depressive symptoms in the elderly with Alzheimer's disease
Lebedeva A, Westman E, Lebedev Av, Li X, Winblad B, Simmons A, et al
Journal of neurology, neurosurgery, and psychiatry 2014;85(8):930-5

The association between biomarkers in cerebrospinal fluid and structural changes in the brain in patients with Alzheimer's disease
Li X, Li Tq, Andreasen N, Wiberg Mk, Westman E, Wahlund Lo
Journal of internal medicine 2014;275(4):418-27

The effects of intracranial volume adjustment approaches on multiple regional MRI volumes in healthy aging and Alzheimer's disease
Alzheimer's Dis Neuroimaging, Voevodskaya O, Simmons A, Nordenskjold R, Kullberg J, Ahlstrom H, et al
FRONTIERS IN AGING NEUROSCIENCE 2014;:264-

TheHiveDB image data management and analysis framework
Muehlboeck Js, Westman E, Simmons A
Frontiers in neuroinformatics 2014;7():49-

An MRI-based index to measure the severity of Alzheimer's disease-like structural pattern in subjects with mild cognitive impairment
Spulber G, Simmons A, Muehlboeck Js, Mecocci P, Vellas B, Tsolaki M, et al
Journal of internal medicine 2013;273(4):396-409

CERAD Neuropsychological Total Scores Reflect Cortical Thinning in Prodromal Alzheimer's Disease
Paajanen T, Hänninen T, Aitken A, Hallikainen M, Westman E, Wahlund Lo, et al
Dementia and geriatric cognitive disorders extra 2013;3(1):446-58

Classification and prediction of clinical diagnosis of Alzheimer's disease based on MRI and plasma measures of α-/γ-tocotrienols and γ-tocopherol
Mangialasche F, Westman E, Kivipelto M, Muehlboeck Js, Cecchetti R, Baglioni M, et al
Journal of internal medicine 2013;273(6):602-21

Demography, diagnostics, and medication in dementia with Lewy bodies and Parkinson's disease with dementia: data from the Swedish Dementia Quality Registry (SveDem)
Fereshtehnejad Sm, Religa D, Westman E, Aarsland D, Lökk J, Eriksdotter M
Neuropsychiatric disease and treatment 2013;9():927-35

Different multivariate techniques for automated classification of MRI data in Alzheimer's disease and mild cognitive impairment
Addneuromed Consortium, Aguilar C, Westman E, Muehlboeck Js, Mecocci P, Vellas B, et al
PSYCHIATRY RESEARCH-NEUROIMAGING 2013;212(2):89-98

Entorhinal Cortex Thickness Predicts Cognitive Decline in Alzheimer's Disease
Addneuromed Consortium, Velayudhan L, Proitsi P, Westman E, Muehlboeck Js, Mecocci P, et al
JOURNAL OF ALZHEIMERS DISEASE 2013;33(3):755-66

Multivariate classification of patients with Alzheimer's and dementia with Lewy bodies using high-dimensional cortical thickness measurements: an MRI surface-based morphometric study
Lebedev Av, Westman E, Beyer Mk, Kramberger Mg, Aguilar C, Pirtosek Z, et al
Journal of neurology 2013;260(4):1104-15

Ratio of Aβ42/P-tau181p in CSF is associated with aberrant default mode network in AD
Li X, Li Tq, Andreasen N, Wiberg Mk, Westman E, Wahlund Lo
Scientific reports 2013;3():1339-

Regional Magnetic Resonance Imaging Measures for Multivariate Analysis in Alzheimer's Disease and Mild Cognitive Impairment
Westman E, Aguilar C, Muehlboeck Js, Simmons A
BRAIN TOPOGRAPHY 2013;26(1):9-23

[Structural brain imaging may improve diagnostics in dementia]
Wahlund Lo, Westman E, Van Westen D, Wallin A, Cavallin L, Larsson Em
Lakartidningen 2013;110(47):2116-8

A Comparison Between Volumetric Data Generated by Voxel-Based Morphometry and Manual Parcellation of Multimodal Regions of the Frontal Lobe
Lindberg O, Manzouri A, Westman E, Wahlund Lo
AMERICAN JOURNAL OF NEURORADIOLOGY 2012;33(10):1957-63

Cognitive impairment in patients with Parkinson's disease: diagnosis, biomarkers, and treatment
Svenningsson P, Westman E, Ballard C, Aarsland D
LANCET NEUROLOGY 2012;11(8):697-707

Combining MRI and CSF measures for classification of Alzheimer's disease and prediction of mild cognitive impairment conversion
Westman E, Muehlboeck Js, Simmons A
NEUROIMAGE 2012;62(1):229-38

Education increases reserve against Alzheimer's disease-evidence from structural MRI analysis
Addneuromed Consortium, Liu Yw, Julkunen V, Paajanen T, Westman E, Wahlund Lo, et al
NEURORADIOLOGY 2012;54(9):929-38

Is the subcallosal medial prefrontal cortex a common site of atrophy in Alzheimer's disease and frontotemporal lobar degeneration?
Lindberg O, Westman E, Karlsson S, Ostberg P, Svensson La, Simmons A, et al
FRONTIERS IN AGING NEUROSCIENCE 2012;:32-

Multispectral MRI segmentation of age related white matter changes using a cascade of support vector machines
Damangir S, Manzouri A, Oppedal K, Carlsson S, Firbank Mj, Sonnesyn H, et al
JOURNAL OF THE NEUROLOGICAL SCIENCES 2012;322(1-2):211-6

Plasma Based Markers of [C-11] PiB-PET Brain Amyloid Burden
Alzheimers Dis Neuroimaging Initia, Kiddle Sj, Thambisetty M, Simmons A, Riddoch-contreras J, Hye A, et al
PLOS ONE 2012;7(9):e44260-

1H-MRS in spinal cord injury: acute and chronic metabolite alterations in rat brain and lumbar spinal cord
Erschbamer M, Oberg J, Westman E, Sitnikov R, Olson L, Spenger C
EUROPEAN JOURNAL OF NEUROSCIENCE 2011;33(4):678-88

AddNeuroMed and ADNI: Similar patterns of Alzheimer's atrophy and automated MRI classification accuracy in Europe and North America
Addneuromed Consortium, Alzheimer's Dis Neuroimaging Initi, Westman E, Simmons A, Muehlboeck Js, Mecocci P, et al
NEUROIMAGE 2011;58(3):818-28

Combination analysis of neuropsychological tests and structural MRI measures in differentiating AD, MCI and control groups-The AddNeuroMed study
Addneuromed Consortium, Liu Yw, Paajanen T, Zhang Y, Westman E, Wahlund Lo, et al
NEUROBIOLOGY OF AGING 2011;32(7):1198-206

Glucose metabolism and PIB binding in carriers of a His163Tyr presenilin 1 mutation
Scholl M, Almkvist O, Axelman K, Stefanova E, Wall A, Westman E, et al
NEUROBIOLOGY OF AGING 2011;32(8):1388-99

Magnetic Resonance Imaging and Magnetic Resonance Spectroscopy for Detection of Early Alzheimer's Disease
Westman E, Wahlund Lo, Foy C, Poppe M, Cooper A, Murphy D, et al
JOURNAL OF ALZHEIMERS DISEASE 2011;:307-19

Multivariate analysis of MRI data for Alzheimer's disease, mild cognitive impairment and healthy controls
Addneuromed Consortium, Westman E, Simmons A, Zhang Y, Muehlboeck Js, Tunnard C, et al
NEUROIMAGE 2011;54(2):1178-87

Plasma Biomarkers of Brain Atrophy in Alzheimer's Disease
Addneuromed Consortium, Thambisetty M, Simmons A, Hye A, Campbell J, Westman E, et al
PLOS ONE 2011;6(12):e28527-

Sensitivity and Specificity of Medial Temporal Lobe Visual Ratings and Multivariate Regional MRI Classification in Alzheimer's Disease
Addneuromed Consortium, Westman E, Cavallin L, Muehlboeck Js, Zhang Y, Mecocci P, et al
PLOS ONE 2011;6(7):e22506-

The AddNeuroMed framework for multi-centre MRI assessment of Alzheimer's disease : experience from the first 24 months
Addneuromed Consortium, Simmons A, Westman E, Muehlboeck S, Mecocci P, Vellas B, et al
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY 2011;26(1):75-82

Analysis of regional MRI volumes and thicknesses as predictors of conversion from mild cognitive impairment to Alzheimer's disease
Addneuromed Consortium, Liu Yw, Paajanen T, Zhang Y, Westman E, Wahlund Lo, et al
NEUROBIOLOGY OF AGING 2010;31(8):1375-85

APOE epsilon 2 Allele Is Associated with Larger Regional Cortical Thicknesses and Volumes
Addneuromed Consortium, Liu Yw, Paajanen T, Westman E, Zhang Y, Wahlund Lo, et al
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS 2010;30(3):229-37

Association of Plasma Clusterin Concentration With Severity, Pathology, and Progression in Alzheimer Disease
Thambisetty M, Simmons A, Velayudhan L, Hye A, Campbell J, Zhang Y, et al
ARCHIVES OF GENERAL PSYCHIATRY 2010;67(7):739-48

Combining MRI and MRS to Distinguish Between Alzheimer's Disease and Healthy Controls
Westman E, Wahlund Lo, Foy C, Poppe M, Cooper A, Murphy D, et al
JOURNAL OF ALZHEIMERS DISEASE 2010;22(1):171-81

Effect of APOE epsilon 4 Allele on Cortical Thicknesses and Volumes: The AddNeuroMed Study
Addneuromed Consortium, Liu Yw, Paajanen T, Westman E, Wahlund Lo, Simmons A, et al
JOURNAL OF ALZHEIMERS DISEASE 2010;21(3):947-66

In vivo H-1-magnetic resonance spectroscopy can detect metabolic changes in APP/PS1 mice after donepezil treatment
Westman E, Spenger C, Oberg J, Reyer H, Pahnke J, Wahlund Lo
BMC NEUROSCIENCE 2009;:33-

MRI Measures of Alzheimer's Disease and the AddNeuroMed Study
Addneuromed Consortium, Simmons A, Westman E, Muehlboeck S, Mecocci P, Vellas B, et al
BIOMARKERS IN BRAIN DISEASE 2009;:47-55

Age related changes in brain metabolites observed by H-1 MRS in APP/PS1 mice
Oberg J, Spenger C, Wang Fh, Andersson A, Westman E, Skoglund P, et al
NEUROBIOLOGY OF AGING 2008;29(9):1423-33

Reorganization of sensory processing below the level of spinal cord injury as revealed by fMRl
Endo T, Spenger C, Westman E, Tominaga T, Olson L
EXPERIMENTAL NEUROLOGY 2008;209(1):155-60

Carbamazepine treatment recovered low N-acetylaspartate plus N-acetylaspartylglutamate (tNAA) levels in the megencephaly mouse BALB/cByJ-Kv1.1(mceph/mceph)
Westman E, Spenger C, Wahlund Lo, Lavebratt C
NEUROBIOLOGY OF DISEASE 2007;26(1):221-8

Kv1.1 null mice have enlarged hippocampus and ventral cortex
Persson As, Westman E, Wang Fh, Khan Fh, Spenger C, Lavebratt C
BMC NEUROSCIENCE 2007;:10-

Blood oxygenation level-dependent visualization of synaptic relay stations of sensory pathways along the neuroaxis in response to graded sensory stimulation of a limb
Lilja J, Endo T, Hofstetter C, Westman E, Young J, Olson L, et al
JOURNAL OF NEUROSCIENCE 2006;26(23):6330-6

Show all publications